Cited by 34Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 355 of the 355 references it cites were found in a registry or an index.

Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions

Archer, Trevor, Kostrzewa, Richard M., Beninger, Richard J., Palomo, Tomas·2011·Neurotoxicity Research

DOI 10.1007/s12640-010-9190-2

Open this paper in CoChat — free account

Abstract

The notion of staging in the neurodegenerative disorders is modulated by the constant and progressive loss of several aspects of brain structural integrity, circuitry, and neuronal processes. These destructive processes eventually remove individuals' abilities to perform at sufficient and necessary functional capacity at several levels of disease severity. The classification of (a) patients on the basis of diagnosis, risk prognosis, and intervention outcome, forms the basis of clinical staging, and (b) laboratory animals on the basis of animal model of brain disorder, extent of insult, and dysfunctional expression, provides the components for the clinical staging and preclinical staging, respectively, expressing associated epidemiological, biological, and genetic characteristics. The major focus of clinical staging in the present account stems from the fundamental notions of Braak staging as they describe the course and eventual prognosis for Alzheimer's disease, Lewy Body dementia, and Parkinson's disease. Mild cognitive impairment, which expresses the decline in episodic and semantic memory performance below the age-adjusted normal range without marked loss of global cognition or activities of daily living, and the applications of longitudinal magnetic resonance imaging, major instruments for the monitoring of either disease progression in dementia, present important challenges for staging concepts. Although Braak notions present the essential basis for further developments, current staging conceptualizations seem inadequate to comply with the massive influx of information dealing with neurodegenerative processes in brain, advanced both under clinical realities, and discoveries in the laboratory setting. The contributions of various biomarkers of disease progression, e.g., amyloid precursor protein, and neurotransmitter system imbalances, e.g., dopamine receptor supersensitivity and interactive propensities, await their incorporation into the existing staging models thereby underlining the ongoing, dynamic feature of the staging of brain disorders.

Integrity signals

Registry

Crossref · 10.1007/s12640-010-9190-2

Cites

355 of 355 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Items 201–355 of 355

Cognitive and Neuropsychiatric Profile of the Synucleinopathies
Kao, A. W., Racine, C. A., Quitania, L., Kramer, J. H., Christine, C. W., & Miller, B. L. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181b5065d · Cited by 133
Regional Distribution of α-Synuclein Pathology in Unimpaired Aging and Alzheimer Disease
Parkkinen, L., Soininen, H. S., & Alafuzoff, I. I. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.363 · Cited by 129
Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study
Wakisaka, Y., Furuta, A., Tanizaki, Y., Kiyohara, Y., Iida, M., & Iwaki, T. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0750-x · Cited by 129
Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia
Kövari, E., Gold, G., Herrmann, F. R., Canuto, A., Hof, P. R., Bouras, C., & Giannakopoulos, P. (2007) · Neurology · doi:10.1212/01.wnl.0000257094.10655.9a · Cited by 128
Evidence in favor of Braak staging of Parkinson's disease
Dickson, D. W., Uchikado, H., Fujishiro, H., & Tsuboi, Y. (2010) · Movement Disorders · doi:10.1002/mds.22637 · Cited by 126
Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome
Hu, W. T., Rippon, G. W., Boeve, B. F., Knopman, D. S., Petersen, R. C., Parisi, J. E., & Josephs, K. A. (2009) · Movement Disorders · doi:10.1002/mds.22574 · Cited by 126
Frontal-Subcortical Dementias
Bonelli, R. M., & Cummings, J. L. (2008) · The Neurologist · doi:10.1097/nrl.0b013e31815b0de2 · Cited by 125
Semantic memory activation in amnestic mild cognitive impairment
Woodard, J. L., Seidenberg, M., Nielson, K. A., Antuono, P., Guidotti, L. M., Durgerian, S., Zhang, Q., Lancaster, M. A., Hantke, N. C., Butts, A. M., et al. (2009) · Brain · doi:10.1093/brain/awp157 · Cited by 124
Progression of Atrophy in Alzheimer’s Disease and Related Disorders
Whitwell, J. L. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9175-1 · Cited by 122
Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study
Meguro, K. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.3.315 · Cited by 119
Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?
Ince, P. G., Perry, E. K., & Morris, C. M. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00156.x · Cited by 116
The progression of Parkinson disease
Lang, A. E. (2007) · Neurology · doi:10.1212/01.wnl.0000257110.91041.5d · Cited by 116
The many faces of corticobasal degeneration
Wadia, P. M., & Lang, A. E. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70027-0 · Cited by 114
Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson’s disease
Halliday, G. M., Tredici, K. D., & Braak, H. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_16 · Cited by 113
Population-based neuropathological studies of dementia: design, methods and areas of investigation – a systematic review
ZACCAI, J. H., Ince, P. G., & Brayne, C. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-2 · Cited by 113
Neuropathological Findings in the Very Old: Results from the First 101 Brains of a Population‐based Longitudinal Study of Dementing Disorders
Xuereb, J. H., Brayne, C., Dufouil, C., Gertz, H.-J., Wischik, C. M., Harrington, C. R., Mukaetova‐Ladinska, E. B., McGee, M. A., O'SULLIVAN, A., O’Connor, D., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06404.x · Cited by 113
Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia
Haroutunian, V. H., Katsel, P., & Schmeidler, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.021 · Cited by 113
Concurrent neocortical borreliosis and Alzheimer's disease
MacDonald, A. B., & Miranda, J. M. (1987) · Human Pathology · doi:10.1016/s0046-8177(87)80252-6 · Cited by 112
Rate of entorhinal and hippocampal atrophy in incipient and mild AD: Relation to memory function
Stoub, T. R., Rogalski, E. J., Leurgans, S. E., Bennett, D. A., & deToledo‐Morrell, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.003 · Cited by 111
APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis
Crews, L. A., Rockenstein, E. M., & Masliah, E. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0232-6 · Cited by 110
Body Mass Index and Cognitive Decline in Mild Cognitive Impairment
Cronk, B. B., Johnson, D. K., & Burns, J. M. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181a6bf3f · Cited by 109
Long-term cognitive deficits following posterior fossa tumor resection: A neuropsychological and functional neuroimaging follow-up study.
Smet, H. J. D., Baillieux, H., Wackenier, P., Praeter, M. D., Engelborghs, S., Paquier, P. F., Deyn, P. P. D., & Mariën, P. (2009) · Neuropsychology · doi:10.1037/a0016106 · Cited by 107
Crossed Cerebellar Diaschisis in Acute Stroke Detected by Dynamic Susceptibility Contrast MR Perfusion Imaging
Lin, D. D. M., Kleinman, J. T., Wityk, R. J., Gottesman, R. F., Hillis, A. E., Lee, A. W., & Barker, P. B. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1435 · Cited by 107
Amyloid Precursor Protein Regulates Differentiation of Human Neural Stem Cells
Kwak, Y.-D., Brannen, C. L., Qu, T., Kim, H. M., Dong, X., Soba, P., Majumdar, A., Kaplan, A., Beyreuther, K. T., & Sugaya, K. (2006) · Stem Cells and Development · doi:10.1089/scd.2006.15.381 · Cited by 105
Medial temporal atrophy and memory impairment in early stage of Alzheimer’s disease: an MRI volumetric and memory assessment study
Mizuno, K., Wakai, M., Takeda, A., & Sobue, G. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00289-0 · Cited by 105
Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease
Cubo, E., Martín, P. M., Martin‐Gonzalez, J. A., Rodríguez‐Blázquez, C., Kulisevsky, J., & ELEP Group Members (2009) · Movement Disorders · doi:10.1002/mds.22896 · Cited by 98
Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies
Katsuse, O., Iseki, E., Marui, W., & Kosaka, K. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00037-6 · Cited by 98
Microstructural Diffusion Changes are Independent of Macrostructural Volume Loss in Moderate to Severe Alzheimer's Disease
Canu, E., McLaren, D. G., Fitzgerald, M. E., Bendlin, B. B., Zoccatelli, G., Alessandrini, F., Pizzini, F. B., Ricciardi, G. K., Beltramello, A., Johnson, S. C., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1295 · Cited by 96
The Natural History of Parkinson’s Disease in the Pre-Levodopa and Post-Levodopa Eras
Hoehn, M. M. M. (1992) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30213-5 · Cited by 95
Staging of Sporadic Parkinson Disease-Related α-Synuclein Pathology: Inter- and Intra-Rater Reliability
Müller, C. M., de Vos, R. A. I., Maurage, C., Thal, D. R., Tolnay, M., & Braak, H. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000171652.40083.15 · Cited by 94
Differential Associations Between Entorhinal and Hippocampal Volumes and Memory Performance in Older Adults.
Rosen, A. C., Prull, M. W., Gabrieli, J. D. E., Stoub, T. R., O'Hara, R. M., Friedman, L., Yesavage, J. A., & deToledo‐Morrell, L. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.6.1150 · Cited by 91
Detecting hippocampal hypometabolism in Mild Cognitive Impairment using automatic voxel-based approaches
Mevel, K., Desgranges, B., Baron, J., Landeau, B., Sayette, V. D. L., Viader, F., Eustache, F., & Chételat, G. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.04.048 · Cited by 90
Magnetic Resonance Imaging in Lewy Body Dementias
Watson, R., Blamire, A. M., & O'Brien, J. T. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000264614 · Cited by 90
Predicting Rapid Clinical Progression in Amnestic Mild Cognitive Impairment
Ahmed, S., Mitchell, J., Arnold, R. J., Nestor, P. J., & Hodges, J. R. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000113014 · Cited by 89
α‐Synuclein pathology is highly dependent on the case selection
Parkkinen, L., Soininen, H. S., Laakso, M., & Alafuzoff, I. I. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2001.00342.x · Cited by 86
Hippocampal atrophy and disconnection in incipient and mild Alzheimer's disease
deToledo‐Morrell, L., Stoub, T. R., & Wang, C. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)63040-4 · Cited by 84
Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: Relationship with the progression of Alzheimer's disease
Akram, A., Christoffel, D. J., Rocher, A. B., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Herrmann, F. R., Haroutunian, V. H., Giannakopoulos, P., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.007 · Cited by 84
Neurologic manifestations of varicella zoster virus infections
Amlie‐Lefond, C., & Jubelt, B. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0064-z · Cited by 81
Clinicopathological Outline of Dementia with Lewy Bodies Applying the Revised Criteria: The Hisayama Study
Fujimi, K., Sasaki, K., Noda, K., Wakisaka, Y., Tanizaki, Y., Matsui, Y., Sekita, A., Iida, M., Kiyohara, Y., Kanba, S., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00169.x · Cited by 79
Effects of ApoE-ɛ4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons
Crivello, F., Lemaître, H., Dufouil, C., Grassiot, B., Delcroix, N., Tzourio‐Mazoyer, N., Tzourio, C., & Mazoyer, B. M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.116 · Cited by 78
The Progression of Alzheimer’s Disease from Limbic Regions to the Neocortex: Clinical, Radiological and Pathological Relationships
Nagy, Z., Hindley, N., Braak, H., Braak, E., Yilmazer‐Hanke, D., Schultz, C., Barnetson, L. P. D., KING, E., Jobst, K. A., & Smith, A. D. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017111 · Cited by 78
Biomarkers for cognitive impairment and dementia in elderly people
Sonnen, J. A., Montine, K. S., Quinn, J. F., Kaye, J. A., Breitner, J. C. S., & Montine, T. J. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70162-5 · Cited by 78
Targeting the Progression of Parkinsons Disease
George, J., Mok, S., Moses, D., Wilkins, S., Bush, A., Cherny, R., & Finkelstein, D. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602814 · Cited by 77
Preclinical (premotor) Parkinson’s disease
Wolters, E. C., Francot, C. M. J. E., Bergmans, P., Winogrodzka, A., Booij, J., Berendse, H. W., & Stoof, J. C. (2000) · Journal of Neurology · doi:10.1007/pl00022910 · Cited by 76
Evidence of Altered Posteromedial Cortical fMRI Activity in Subjects at Risk for Alzheimer Disease
Pihlajamaki, M. M., O’Keefe, K., Bertram, L., Tanzi, R. E., Dickerson, B. C., Blacker, D., Albert, M., & Sperling, R. A. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181a785c9 · Cited by 76
Assessment of changes in regional cerebral blood flow in patients with major depression using the 99mTc-HMPAO single photon emission tomography method
Yazici, M. K., Kapucu, �., Erbaş, B., Varoğlu, E., G�lec, C., & Cf, B. (1992) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00180865 · Cited by 76
A multicenter 1 H-MRS study of the medial temporal lobe in AD and MCI
Jessen, F., Gür, O., Block, W., Ende, G., Frölich, L., Hammen, T., Wiltfang, J., Kucinski, T., Jahn, H., Heun, R., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a60a20 · Cited by 76
The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT.
Holman, B. L., Johnson, K. A., Gerada, B., Carvalho, P. A., & Satlin, A. (1992) · PubMed · Cited by 73
Role of Infection in the Pathogenesis of Alzheimerʼs Disease
Holmes, C., & Cotterell, D. (2009) · CNS Drugs · doi:10.2165/11310910-000000000-00000 · Cited by 71
Nonmotor fluctuations in Parkinson's disease: Clinical spectrum and classification
Bayülkem, K., & Lopez, G. J. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.022 · Cited by 71
Executive functions in frontotemporal dementia and Lewy body dementia.
Johns, E. K., Phillips, N. A., Belleville, S., Goupil, D., Babins, L., Kelner, N., Ska, B., Gilbert, B., Inglis, G., Panisset, M., et al. (2009) · Neuropsychology · doi:10.1037/a0016792 · Cited by 70
Controversies over the staging of α-synuclein pathology in Parkinson’s disease
Kalaitzakis, M. E., Graeber, M. B., Gentleman, S. M., & Pearce, R. K. B. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0381-3 · Cited by 68
Three‐Layered Structure Shared Between Lewy Bodies and Lewy Neurites—Three‐Dimensional Reconstruction of Triple‐Labeled Sections
Kanazawa, T., Uchihara, T., Takahashi, A., Nakamura, A., Orimo, S., & Mizusawa, H. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00140.x · Cited by 67
Retina thickness in Parkinson's disease and essential tremor
Cubo, E., Tedejo, R. P., Méndez, V. R., Peña, M. J. L., & y Galán, J. M. T. G. (2010) · Movement Disorders · doi:10.1002/mds.23215 · Cited by 67
The functional neurophysiology of the amyloid precursor protein (APP) processing pathway
Randall, A. D., Witton, J., Booth, C., Hynes-Allen, A. M., & Brown, J. T. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.011 · Cited by 66
Assessments of the accumulation severities of amyloid β-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains
Zhou, X., Li, X., Björkdahl, C., Sjögren, M. J. C., Alafuzoff, I. I., Soininen, H. S., Grundke, I., Iqbal, K., Winblad, B. G., & Pei, J.-J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.006 · Cited by 65
Rabies viral encephalitis: clinical determinants in diagnosis with special reference to paralytic form
Gadre, G., Satishchandra, P., Mahadevan, A., Suja, M. S., Madhusudana, S. N., Sundaram, C., & Shankar, S. K. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.185504 · Cited by 65
α-Synuclein Aggregates Interfere with Parkin Solubility and Distribution
Kawahara, K., Hashimoto, M., Bar‐On, P., Ho, G. J., Crews, L. A., Mizuno, H., Rockenstein, E. M., Imam, S. Z., & Masliah, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710418200 · Cited by 64
Changes in hippocampal GABABR1 subunit expression in Alzheimer’s patients: association with Braak staging
Iwakiri, M., Mizukami, K., Ikonomović, M. D., Ishikawa, M., Hidaka, S., Abrahamson, E. E., DeKosky, S. T., & Asada, T. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-0985-9 · Cited by 64
Lexical and semantic fluency discrepancy scores in aMCI and early Alzheimer's disease
Lonie, J. A., Herrmann, L. L., Tierney, K. M., Donaghey, C. L., O’Carroll, R. E., Lee, A., & Ebmeier, K. P. (2008) · Journal of Neuropsychology · doi:10.1348/174866408x289935 · Cited by 62
Symmetric corticobasal degeneration (S-CBD)
Hassan, A., Whitwell, J. L., Boeve, B. F., Jack, C. R., Parisi, J. E., Dickson, D. W., & Josephs, K. A. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.11.013 · Cited by 61
α-Synuclein pathology in the neostriatum in Parkinson’s disease
Mori, F., Tanji, K., Zhang, H., Kakita, A., Takahashi, H., & Wakabayashi, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0316-4 · Cited by 61
Cortical Lewy body disease and Parkinson's disease dementia
Burn, D. J. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000247607.34697.a2 · Cited by 60
The Benefit of a Home Exercise Regimen for Ambulatory Parkinsonʼs Disease Patients
Hurwitz, A. (1989) · Journal of Neuroscience Nursing · doi:10.1097/01376517-198906000-00008 · Cited by 60
Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: Two individual consequences of CUG trinucleotide repeats
Dhaenens, C., Schraen‐Maschke, S., Tran, H., Vingtdeux, V., Ghanem, D., Leroy, O., Delplanque, J., Vanbrussel, E., Delacourte, A., Vermersch, P., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.020 · Cited by 59
Frontotemporal Dementia Mimicking Dementia With Lewy Bodies
Claassen, D. O., Parisi, J. E., Giannini, C., Boeve, B. F., Dickson, D. W., & Josephs, K. A. (2008) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3181864a09 · Cited by 58
Exercise alleviates Parkinsonism: clinical and laboratory evidence
Archer, T., Fredriksson, A., & Johansson, B. B. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01360.x · Cited by 55
Self-citation
Linking Hippocampal Structure and Function to Memory Performance in an Aging Population
Reitz, C., Brickman, A. M., Brown, T. R., Manly, J. J., DeCarli, C. S., Small, S. A., & Mayeux, R. P. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.214 · Cited by 55
Clinical referral patterns and cognitive profile in mild cognitive impairment
Lonie, J. A., Herrmann, L. L., Donaghey, C. L., & Ebmeier, K. P. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.035642 · Cited by 53
Interaction Between Dopamine and Phospholipids
Riekkinen, P. J. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490430047006 · Cited by 52
Current concepts in the management of Parkinson disease
Hayes, M. W., Fung, V. S. C., Kimber, T. E., & O’Sullivan, J. D. (2010) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb03453.x · Cited by 51
Impact of dopamine–glutamate interactions on striatal neuronal nitric oxide synthase activity
Hoque, K. E., Indorkar, R. P., Sammut, S., & West, A. R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1687-0 · Cited by 51
Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia
Kawanabe, T., Yoritaka, A., Shimura, H., Oizumi, H., Tanaka, S., & Hattori, N. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.11.019 · Cited by 51
Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus
Akram, A., Schmeidler, J., Katsel, P., Hof, P. R., & Haroutunian, V. (2010) · Brain Research · doi:10.1016/j.brainres.2010.01.006 · Cited by 50
Diagnosis and staging of mild cognitive impairment, using a modification of the clinical dementia rating scale: the mCDR
Duara, R., Loewenstein, D., Greig‐Custo, M. T., Raj, A., Barker, W., Potter, E., Schofield, E., Small, B. J., Schinka, J. A., Wu, Y., et al. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2334 · Cited by 50
Relationship between Clinical and Radiological Diagnostic Criteria for Alzheimer’s Disease and the Extent of Neuropathology as Reflected by ‘Stages’: A Prospective Study
Nagy, Z., Hindley, N., Braak, H., Braak, E., Yilmazer‐Hanke, D., Schultz, C., Barnetson, L. P. D., Jobst, K. A., & Smith, A. D. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017110 · Cited by 49
Severity of Medial Temporal Atrophy and Amnestic Mild Cognitive Impairment: Selecting Type and Number of Memory Tests
Loewenstein, D., Acevedo, A., Potter, E. L., Schinka, J. A., Raj, A., Greig, M. T., Agrón, J., Barker, W., Wu, Y., Small, B. J., et al. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181b7ef42 · Cited by 49
Sleep Disturbances in Parkinson Disease and Their Potential Role in Heterogeneity
Gunn, D. G., Naismith, S. L., & Lewis, S. J. G. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988709358591 · Cited by 49
Howard Henry Tooth (1856-1925)
Pearce, J. (2000) · Journal of Neurology · doi:10.1007/s004150050002 · Cited by 46
Dopamine receptor supersensitivity: Development, mechanisms, presentation, and clinical applicability
Kostrzewa, R. M., Kostrzewa, J. P., Brown, R. W., Nowak, P. G., & Brus, R. (2008) · Neurotoxicity Research · doi:10.1007/bf03033804 · Cited by 46
Self-citation
Alzheimer’s neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes
MacDonald, A. B. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.08.043 · Cited by 45
Stem cell strategies for Alzheimer's disease therapy.
Sugaya, K., Alvarez, A. M., Marutle, A., Yd, K., & Choumkina, E. (2006) · PubMed · Cited by 45
Expression of Varicella-Zoster Virus Immediate-Early Regulatory Protein IE63 in Neurons of Latently Infected Human Sensory Ganglia
Zerboni, L., Sobel, R. A., Ramachandran, V. V., Rajamani, J., Ruyechan, W. T., Abendroth, A., & Arvin, A. M. (2010) · Journal of Virology · doi:10.1128/jvi.02416-09 · Cited by 42
Structural and Metabolic Correlates of Episodic Memory in Relation to the Depth of Encoding in Normal Aging
Kalpouzos, G., Chételat, G., Landeau, B., Clochon, P., Viader, F., Eustache, F., & Desgranges, B. (2008) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2008.21027 · Cited by 42
Medial Temporal Lobe Correlates of Memory Screening Measures in Normal Aging, MCI, and AD
Sánchez‐Benavides, G., Gómez‐Ansón, B., Molinuevo, J. L., Blesa, R., Monté, G. C., Herman Buschke, L., & Peña‐Casanova, J. (2009) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988709355271 · Cited by 41
Practical Issues in Stem Cell Therapy for Alzheimers Disease
Sugaya, K., Kwak, Y., Ohmitsu, O., Marutle, A., Greig, N. H., & Choumrina, E. (2007) · Current Alzheimer Research · doi:10.2174/156720507781788936 · Cited by 41
Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment
Jauhiainen, A. M., Pihlajamaki, M. M., Tervo, S., Niskanen, E. I., Tanila, H., Hänninen, T., Vanninen, R. L., & Soininen, H. S. (2008) · Hippocampus · doi:10.1002/hipo.20494 · Cited by 41
Evaluation of Parkinson’s Disease: Reliability of Three Rating Scales
Ginanneschi, A., Degl'Innocenti, F., Magnolfi, S., Maurello, M. T., Catarzi, L., Marini, P., & Amaducci, L. A. (1987) · Neuroepidemiology · doi:10.1159/000110159 · Cited by 40
Physical Exercise Attenuates MPTP-Induced Deficits in Mice
Archer, T., & Fredriksson, A. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9168-0 · Cited by 40
Self-citation
Lyme Disease Associated with Alzheimer’s Disease
Meer-Scherrer, L., Loa, C. C., Adelson, M. E., Mordechai, E., Lobrinus, J. A., Fallon, B. A., & Tilton, R. C. (2006) · Current Microbiology · doi:10.1007/s00284-005-0454-7 · Cited by 39
Childhood herpes zoster: A clustering of ten cases
Prabhu, S. S., Sripathi, H., Gupta, S., & Prabhu, M. M. (2009) · Indian Journal of Dermatology · doi:10.4103/0019-5154.48991 · Cited by 39
Progression patterns of neuronal loss and Lewy body pathology in the substantia nigra in Parkinson's disease
Wakabayashi, K., Mori, F., & Takahashi, H. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.05.028 · Cited by 39
Clinical Features of Mild Cognitive Impairment Differ in the Research and Tertiary Clinic Settings
Jicha, G. A., Abner, E. L., Schmitt, F. A., Cooper, G. E., Stiles, N. J., Hamon, R., Carr, S., Smith, C. D., & Markesbery, W. R. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000151635 · Cited by 38
α-Synuclein multiplication analysis in Italian familial Parkinson disease
Sironi, F. M., Trotta, L., Antonini, A., Zini, M., Ciccone, R., Mina, E. D., Meucci, N., Sacilotto, G., Primignani, P., Brambilla, T., et al. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.09.008 · Cited by 38
Cognitive and Personality Features in Parkinson Disease: 2 Sides of the Same Coin?
Volpato, C., Signorini, M., Meneghello, F., & Semenza, C. (2009) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3181c12c63 · Cited by 37
Lewy Body Variant of Alzheimer's Disease: Selective Neocortical Loss of t-SNARE Proteins and Loss of MAP2 and α-Synuclein in Medial Temporal Lobe
Mukaetova‐Ladinska, E. B., Xuereb, J. H., García‐Sierra, F., Hurt, J., Gertz, H.-J., Hills, R., Brayne, C., Huppert, F. A., Paykel, E. S., McGee, M. A., et al. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.151 · Cited by 36
Early symptoms and signs of cognitive deficits might not always be detectable in persons who develop Alzheimer's disease
Palmer, K., Bäckman, L., Winblad, B. G., & Fratiglioni, L. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207006564 · Cited by 34
Relating Medial Temporal Lobe Volume to Frontal fMRI Activation for Memory Encoding in Older Adults
Rosen, A. C., Gabrieli, J. D. E., Stoub, T. R., Prull, M. W., O'Hara, R. M., Yesavage, J. A., & deToledo‐Morrell, L. (2005) · Cortex · doi:10.1016/s0010-9452(08)70199-0 · Cited by 33
Quantitative estimation of regional brain iron with magnetic resonance imaging
Martin, W. R. W. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70818-1 · Cited by 32
Biomarkers in Huntington's and Parkinson's Disease
O’Keeffe, G. C., Michell, A. W., & Barker, R. A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04943.x · Cited by 31
Non‐uniformity in the regional pattern of Lewy pathology in brains of dementia with Lewy bodies
Yamamoto, R., Iseki, E., Marui, W., Togo, T., Katsuse, O., Kato, M., Isojima, D., Akatsu, H., Kosaka, K., & Arai, H. (2005) · Neuropathology · doi:10.1111/j.1440-1789.2005.00627.x · Cited by 31
Amyloid-β Precursor Protein Induces Glial Differentiation of Neural Progenitor Cells by Activation of the IL-6/gp130 Signaling Pathway
Kwak, Y.-D., Dantuma, E., Merchant, S., Bushnev, S., & Sugaya, K. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9170-6 · Cited by 30
Epigenetics and Biomarkers in the Staging of Neuropsychiatric Disorders
Archer, T., Beninger, R. J., Palomo, T., & Kostrzewa, R. M. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9163-5 · Cited by 30
Self-citation
Frequency and clinical features of Lewy body dementia in Italian memory clinics.
Farina, E., Baglio, F., Caffarra, P., Magnani, G., Scarpini, E., Appollonio, I. M., Bascelli, C., Cheldi, A., Nemni, R., Franceschi, M., et al. (2009) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 29
Dopamine receptor supersensitivity: An outcome and index of neurotoxicity
Kostrzewa, R. M., Kostrzewa, J. P., & Brus, R. (2003) · Neurotoxicity Research · doi:10.1007/bf03033376 · Cited by 29
Self-citation
Alpha-synuclein is not a requisite component of synaptic boutons in the adult human central nervous system
Braak, H., Tredici, K. D., Gai, W., & Braak, E. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00101-0 · Cited by 28
Functional response in ventral temporal cortex differentiates mild cognitive impairment from normal aging
Gold, B. T., Jiang, Y., Jicha, G. A., & Smith, C. D. (2010) · Human Brain Mapping · doi:10.1002/hbm.20932 · Cited by 27
Controlled Memory Processes in Questionable Alzheimer's Disease: A View from Neuroimaging Research
Bastin, C., Kerrouche, N., Lekeu, F., Adam, S., Guillaume, B., Lemaire, C. F., Aerts, J. J., d’Ydewalle, G., Collette, F., & Salmon, É. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1393 · Cited by 26
5-123I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment
Terrière, E., Dempsey, M. F., Herrmann, L. L., Tierney, K. M., Lonie, J. A., O’Carroll, R. E., Pimlott, S. L., Wyper, D. J., Herholz, K., & Ebmeier, K. P. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.10.008 · Cited by 26
Alzheimer’s disease Braak Stage progressions: Reexamined and redefined as Borrelia infection transmission through neural circuits
MacDonald, A. B. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.09.054 · Cited by 26
Positional Brain Deformation Visualized With Magnetic Resonance Morphometry
Schnaudigel, S., Preul, C., Ugur, T., Mentzel, H. J., Witte, O. W., Tittgemeyer, M., & Hagemann, G. (2010) · Neurosurgery · doi:10.1227/01.neu.0000363704.74450.b4 · Cited by 25
Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment and Dementia
Sonnen, J. A., Montine, K. S., Quinn, J. F., Breitner, J. C. S., & Montine, T. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1236 · Cited by 24
Mechanism of Glial Differentiation of Neural Progenitor Cells by Amyloid Precursor Protein
Sugaya, K. (2008) · Neurodegenerative Diseases · doi:10.1159/000113693 · Cited by 24
Donepezil Treatment and Changes in Hippocampal Structure in Very Mild Alzheimer Disease
Wang, L., Harms, M. P., Staggs, J. M., Xiong, C., Morris, J. C., Csernansky, J. G., & Galvin, J. E. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.292 · Cited by 24
Mini-Review: Multiple developmental forms of parkinsonism. The basis for further research as to the pathogenesis of parkinsonism
Riederer, P. F., & Foley, P. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200095 · Cited by 24
Imaging the Earliest Stages of Alzheimers Disease
Wu, W. E., & Small, S. A. (2006) · Current Alzheimer Research · doi:10.2174/156720506779025161 · Cited by 23
Frequency and Correlates of Involuntary Emotional Expression Disorder in Parkinson's Disease
Petracca, G., Jorge, R. E., Ación, L., Weintraub, D. A., & Robinson, R. G. (2009) · Journal of Neuropsychiatry · doi:10.1176/jnp.2009.21.4.406 · Cited by 23
The relationship between tangle and plaque formation during healthy aging and mild dementia
Price, J. L. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90062-g · Cited by 22
Cognitive and behavioural impairment in Parkinson's disease
Merims, D., & Freedman, M. (2008) · International Review of Psychiatry · doi:10.1080/09540260802095123 · Cited by 21
Amyloid precursor protein is involved in staurosporine induced glial differentiation of neural progenitor cells
Kwak, Y.-D., Choumkina, E., & Sugaya, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.054 · Cited by 20
Evidence against a reliable staging system of α‐synuclein pathology in Parkinson's disease
Kalaitzakis, M. E., Graeber, M. B., Gentleman, S., & Pearce, R. K. B. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00998.x · Cited by 19
Treatment of Early Parkinson’s Disease
Simuni, T., Lyons, K. E., Pahwa, R., Hauser, R. A., Comella, C. L., Elmer, L. W., & Weintraub, D. A. (2009) · European Neurology · doi:10.1159/000197103 · Cited by 19
Alzheimer disease, in living color
Small, S. A. (2005) · Nature Neuroscience · doi:10.1038/nn0405-404 · Cited by 19
Current and future management of the corticobasal syndrome and corticobasal degeneration
Boeve, B. F., Josephs, K. A., & Drubach, D. A. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01249-3 · Cited by 18
The Effect of Apolipoprotein Polymorphism on Brain in Mild Cognitive Impairment: A Voxel-Based Morphometric Study
Pennanen, C., Testa, C., Boccardi, M., Laakso, M. P., Hallikainen, M., Helkala, E., Hänninen, T., Kivipelto, M., Könönen, M., Nissinen, A. M., et al. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000093263 · Cited by 18
Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment
Fayed, N. M., Dávila, J., Oliveros, A., Medrano, J., & Castillo, J. (2010) · Neurological Research · doi:10.1179/174313209x405164 · Cited by 18
Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D2 receptor agonists
Nowak, P. G., Nitka, D., Kwieciński, A., Jośko, J., Drab, J., Pojda‐Wilczek, D., Kasperski, J., Kostrzewa, R. M., & Brus, R. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70037-4 · Cited by 18
Self-citation
Pinpointing Synaptic Loss Caused by Alzheimer’s Disease with fMRI
Brickman, A. M., Small, S. A., & Fleisher, A. (2009) · Behavioural Neurology · doi:10.1155/2009/246892 · Cited by 18
Evaluation of Parkinson's Disease: A New Approach to Disability
Ginanneschi, A., Degl'Innocenti, F., Maurello, M. T., Magnolfi, S., Marini, P., & Amaducci, L. A. (1991) · Neuroepidemiology · doi:10.1159/000110285 · Cited by 17
Alzheimer's disease: Report of two autopsy cases with a clinical diagnosis of corticobasal degeneration
Okazaki, K., Fu, Y., Nishihira, Y., Endo, M., Fukushima, T., Ikeuchi, T., Okamoto, K., Onodera, O., Nishizawa, M., & Takahashi, H. (2009) · Neuropathology · doi:10.1111/j.1440-1789.2009.01062.x · Cited by 17
α4β2-Nicotinic Receptor Binding with 5-IA in Alzheimer’s Disease: Methods of Scan Analysis
Terrière, E., Sharman, M., Donaghey, C. L., Herrmann, L. L., Lonie, J. A., Strachan, M., Dougall, N. J., Best, J. J. K., Ebmeier, K. P., Pimlott, S. L., et al. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9517-4 · Cited by 16
Creutzfeldt-Jakob, Parkinson, Lewy Body Dementia and Alzheimer Diseases: From Diagnosis to Therapy
Dupiereux-Fettweis, I., Zorzi, W., Quadrio, I., Perret‐Liaudet, A., Kovács, G. G., Heinen, E., & Elmoualij, B. (2009) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152409787601950 · Cited by 16
Acute l-DOPA Effect on Hydroxyl Radical- and DOPAC-Levels in Striatal Microdialysates of Parkinsonian Rats
Nowak, P. G., Kostrzewa, R. A., Skaba, D. R., & Kostrzewa, R. M. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9105-2 · Cited by 15
Self-citation
Influence of Mild Cognitive Impairment on Visual Word Recognition
Bush, A. L. H., Allen, P. A., Kaut, K. P., & Ogrocki, P. K. (2006) · Aging Neuropsychology and Cognition · doi:10.1080/13825580600630278 · Cited by 14
Pinpointing synaptic loss caused by Alzheimer's disease with fMRI.
Brickman, A. M., Small, S. A., & Fleisher, A. (2009) · PubMed · doi:10.3233/ben-2009-0240 · Cited by 14
Early diagnosis in Parkinson's disease.
Przuntek, H. (1992) · PubMed · Cited by 14
The Hippocampal System as the Cortical Resource Manager: A Model Connecting Psychology, Anatomy and Physiology
Coward, L. A. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-79100-5_18 · Cited by 13
Stereotypic Progressions in Psychotic Behavior
Kostrzewa, R. M., Kostrzewa, R. A., Kostrzewa, F. P., Kostrzewa, F. P., Brus, R., & Nowak, P. G. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9192-0 · Cited by 13
Self-citation
The Neuropsychiatric Inventory Scores Change Across the Mini Mental State Examination Ranges in Patients With Alzheimer's Disease: A Multicenter Study in Turkey
Yener, G. (2009) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3181c14737 · Cited by 12
Time sequences of dopaminergic cell death in Parkinson's disease: indications for neuroprotective studies.
Gerlach, M., & Pf, R. (1999) · PubMed · Cited by 11
Diagnosis and Treatment of Parkinson’s Disease — State of the Art
(1999) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6360-3 · Cited by 10
What’s new? Clinical progression and staging of Parkinson’s disease
Goetz, C. G. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_46 · Cited by 9
Imaging‐Guided Microarray
Pereira, A. C., Wu, W. E., & Small, S. A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.005 · Cited by 9
Involvement of NMDA receptors in the ventrolateral striatum of rats in apomorphine-induced jaw movements
Fujita, S., Kiguchi, M., Kobayashi, M., Koshikawa, N., & Waddington, J. L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.01.068 · Cited by 8
Parkinson Disease: Extranigral, Multisystem, and α-Synuclein “Plus”
Kalaitzakis, M. E. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.140 · Cited by 7
Nineteenth century studies of atypical parkinsonism: Charcot and his Salpêtrière School.
Goetz, C. G. (2000) · PubMed · Cited by 7
Masked-Volume-Wise PCA and "reference Logan" illustrate similar regional differences in kinetic behavior in human brain PET study using [11C]-PIB
Razifar, P., Ringheim, A., Engler, H., Hall, H., & Långström, B. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-2 · Cited by 6
Tau, a biological marker of neurodegenerative diseases
Delacourte, A. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01215-8 · Cited by 4
Mild cognitive impairment: unanswered questions and future directions
Jelić, V., Palmer, K., & Winblad, B. G. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.107.s179.14.x · Cited by 4
[Corticobasal degeneration].
Mizusawa, H. (1997) · PubMed · Cited by 4
The substantia nigra in Parkinsonism.
Wolman, L., & Roy, S. (1969) · Journal of Clinical Pathology · doi:10.1136/jcp.22.4.507-d · Cited by 2
Mild cognitive impairment - a five year follow-up and imaging study
Lonie, J. A., Kalu, U. G., Sexton, C. E., Mackay, C. E., Bastin, M. E., Terrière, E., O’Carroll, R. E., & Ebmeier, K. P. (2011) · Stirling Online Research Repository (University of Stirling) · Cited by 1
Chapter 17 Mild Cognitive Impairment: A 5-Year Follow-Up and Imaging Study
Lonie, J. A., Kalu, U. G., Sexton, C. E., Mackay, C. E., Bastin, M. E., Terrière, E., O’Carroll, R. E., & Ebmeier, K. P. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0785-0_17 · Cited by 1
Diagnosis and Treatment of Parkinson's Disease – State of the Art. 1999. Edited by H. Przuntek, T. Muller. Springer Wien New York. 220 C$166.60 approx.
Marras, C. (2001) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100052720 · Cited by 1
Stereotypic Progressions in Psychotic Behavior
Kostrzewa, R. M., Kostrzewa, J. P., Kostrzewa, R. A., Kostrzewa, F. P., Brus, R., & Nowak, P. G. (2010) · Springer eBooks · doi:10.1007/978-1-4614-0785-0_13 · Cited by 1
Self-citation

Research works printed but not linked: 2

Raz N (1996) Neuroanatomy of aging brain: evidence from structural MRI. In: Bigler ED (ed) Neuroimaging II: clinical application. Plenum Press, New York, pp 273–300
Smith CD (2007) Mild cognition impairment is too late: the case for presymptomatic detection and treatment for Alzheimer’s disease. Cogn Sci 3:127–177

Sorted by citations

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
Effects of Physical Activity in Nursing Home Residents with Dementia: A Randomized Controlled Trial
Henskens, M., Nauta, I. M., van Eekeren, M. C. A., & Scherder, E. (2018) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000491818 · Cited by 122
Is Altered BDNF Biosynthesis a General Feature in Patients with Cognitive Dysfunctions?
Carlino, D., Vanna, M. D., & Tongiorgi, E. (2012) · The Neuroscientist · doi:10.1177/1073858412469444 · Cited by 117
Physical exercise alleviates debilities of normal aging and Alzheimer’s disease
Archer, T. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01412.x · Cited by 112
Self-citation
Peripherally Applied Synthetic Peptide isoAsp7-Aβ(1-42) Triggers Cerebral β-Amyloidosis
Kozin, S. A., Cheglakov, I. B., Ovsepyan, A. A., Telegin, G. B., Tsvetkov, P. O., Лисица, А. В., & Makarov, A. А. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9399-y · Cited by 97

See all 34

Authors: Archer, T., Kostrzewa, R. M., Beninger, R. J., & Palomo, T.
Affiliations: University of Gothenburg (SE)
East Tennessee State University (US)
Queen's University (CA)
Corresponding author: Archer, Trevor
ORCID: Kostrzewa, Richard M.
Venue: Neurotoxicity Research
Publisher: Springer Science and Business Media LLC
Published: 2010-04-15
Volume: 19
Issue: 2
Pages: 211-234
ISSN: 1029-8428 (ISSN-L)
1476-3524
DOI: 10.1007/s12640-010-9190-2
OpenAlex: W2001174540
Cited by: 34
References: 355
Citations by year: 2026: 3 · 2023: 3 · 2021: 1 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 8 · 2014: 3 · 2013: 4 · 2012: 3
FWCI: 2.15
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Neurotoxicity Research (publishedVersion)
PubMed (publishedVersion)
Digital Commons - East Tennessee State University (East Tennessee State University) (submittedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords: Braak staging, Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, mild cognitive impairment, disease progression biomarkers, amyloid precursor protein, dopamine receptor supersensitivity, longitudinal MRI, animal models of neurodegeneration, brain structural integrity
MeSH terms: Animals, Humans, Biomarkers, Disease Progression, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks